InChI=1S/C20H32O4/c1-2-3-9-13-18-19(24-18)16-15-17(21)12-10-7-5-4-6-8-11-14-20(22)23/h4,6-7,10,15-19,21H,2-3,5,8-9,11-14H2,1H3,(H,22,23)/b6-4-,10-7-,16-15+/t17-,18-,19-/m0/s1 |
WLMZMBKVRPUYIG-CHDPIHKSSA-N |
C(CCCC)[C@H]1[C@H](\C=C\[C@H](C/C=C\C/C=C\CCCC(O)=O)O)O1 |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
View more via ChEBI Ontology
Outgoing
|
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
has role
human xenobiotic metabolite
(CHEBI:76967)
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
is a
epoxy fatty acid
(CHEBI:61498)
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
is a
hepoxilin
(CHEBI:36200)
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
is a
hydroxy fatty acid
(CHEBI:24654)
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
is a
long-chain fatty acid
(CHEBI:15904)
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
is a
trienoic fatty acid
(CHEBI:73155)
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
is conjugate acid of
11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1−)
(CHEBI:132201)
|
|
Incoming
|
11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1−)
(CHEBI:132201)
is conjugate base of
11(S)-hydroxy-14(S),15(S)-hepoxilin A3
(CHEBI:132886)
|
(5Z,8Z,11S,12E)-11-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoic acid
|
11(S)-14,15-hepoxilin A3
|
ChEBI
|
11(S)-14,15-HxA3
|
ChEBI
|
11(S)-hydroxy-14(S),15(S)-epoxy-5(Z),8(Z),12(E)-eicosatrienoic acid
|
ChEBI
|
11(S)-hydroxy-14(S),15(S)-epoxy-5(Z),8(Z),12(E)-icosatrienoic acid
|
ChEBI
|
14(S),15(S)-hepoxilin A3
|
ChEBI
|
14(S),15(S)-HxA3
|
ChEBI
|
22075237
|
Reaxys Registry Number
|
Reaxys
|
21046276
|
PubMed citation
|
Europe PMC
|
|